Medical Digest & Congress Report

We asked Professor Mark R. Payne about the new results of the SAXOPHONE Study what he presented at the recent ISTH 2022 congress. The study  investigated the use of apixaban in children with heart disease. (A Multi-Center, Multi-National Randomized Trial of Apixaban versus Standard of Care Anticoagulation for Thromboprophylaxis in Children with Congenital or Acquired Heart Disease) Video: htt...

DOACs revolutionize the anticoagulation treatment in the last decade, but we have a few open question yet. We asked Professor James Douketis about the optimal perioperative management with regards to safety and efficacy. Video: https://congressreport.eu/scientific-contents/interview:current-guidelines-perioperative-anticoagulation-management-doacs

Professor Jan Václavík held a lecture at the recent European Society of Hypertension 2022 Congress about the diagnosis of non-adherence in antihypertensive treatment. Video: https://congressreport.eu/scientific-contents/interview:diagnosis-non-adherence-clinical-consultation

Professor Alberico L. Catapano spoke about the European Atherosclerosis Society annual meeting, the novelties presented there, the ESC/EAS joint session discussing the new dyslipidemia guideline. Video: https://congressreport.eu/scientific-contents/interview:esceas-joint-session-deep-dive-prevention-gls-focus-dyslipidemia

At the recent European Society of Hypertension 2022 annual congress, nocturnal hypertension addressed as one of the six hot questions in blood pressure monitoring. Professor Paolo Palatini shared his insights with us on nocturnal hypertension.  Video:  https://congressreport.eu/scientific-contents/interview:nocturnal-hypertension

There are long standing debates around the blood pressure lowering treatment in elderly patients.  Fortunately more and more clinical trials includes older populations. The emerging data has been discussed during the interesting session of the recent European Society of Hypertension 2022 annual congress in Athens. We asked Professor Athanase Benetos who chaired the session to share the key ma...

Professor Giuseppe Mancia spoke about a very interesting session from the recent European Society of Hypertension congress in Athens. The session was about the lifelong burden of hypertension, he talked about vascular aging and other interesting concepts which could put risk charts and risks course into a new perspective. Video: https://congressreport.eu/scientific-contents/interview:lifelong-burd...

Professor Ana Giménez-Arnau chaired a very interesting session about chronic urticaria and the new pathogenic insights about it at the recent EADV symposium in Ljubljana. Video: https://congressreport.eu/scientific-contents/interview:new-pathogenic-insights-chronic-urticaria

Professor Constantine Stratakis  co-chaired a meet the expert session at the 31st European Meeting on Hypertension and Cardiovascular Protection.  He summarized us the main messages of the session on the diagnosis and management of primary aldosteronism.  Video: https://congressreport.eu/scientific-contents/interview:novelties-diagnosis-and-management-primary-aldosteronism

Professor Takayuki Yoshino presented at the recent ASCO 2022 new data about the PARADIGM trial. He summerized us the main findings. (Panitumumab plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 as first‐line treatment in patients with RAS wild‐type metastatic colorectal cancer) Video: https://congressreport.eu/scientific-contents/interview:results-phase-3-paradigm-trial

Professor Florian Kronenberg presented the lipoprotein(a) consensus panel recommendations in the recent European Atherosclerosis Society 2022 Congress in Milan. He summarized for us our current knowledge about the role of lipoprotein(a) in cardiovascular diseases. Video: https://congressreport.eu/scientific-contents/interview:detecting-elevated-lipoprotein-and-addressing-ascvd-risks

Professor Carl Orringer was a co-chair of a recent symposium at the European Atherosclerosis Society 2022 session in Milan. The topic of the discussion was the potential role of the injectable therapies to prevent cardiovascular disease. Video: https://congressreport.eu/scientific-contents/interview:who-needs-injectable-therapies-cholesterol-lowering-or-statins-and-ezetimibe-are-enough-cvd-prevent...

Professor Richard D. Kim presented a data about the long term follow-up of the KEYNOTE-651 study at the recent ASCO 2022 congress. We asked him about the new informations and also about the KEYNOTE-177 trial. Video: https://congressreport.eu/scientific-contents/interview:pembrolizumab-crc-what-did-we-learn-keynote-177-and-keynote-651-trials

Professor Giuseppe Danilo Norata discussed in the interview what is difference between PCSK9 genetic deficiency and PCSK9 pharmacological inhibition. Video: https://congressreport.eu/scientific-contents/interview:difference-between-genetic-and-pharmacological-inhibition-pcsk9

Professor Sibylle Loibl was the recipient of the 2022 ESMO Breast Cancer award for her excepcional contribution the clinical research of Breast Cancer. We asked her about the award an the upcoming new clinical practice guidelines of ESMO for the diagnosis, treatment and follow-up for early breast cancer, which will be published at the ESMO 2022 congress in September. Video: https://congressreport....

Dr. Andrew Blauvelt is the first author of a recent paper which analyzes long-term efficacy and safety of ixekizumab in psoriasis. Dr. Blauvelt tell us what was the message of this study for the dermatologist society and why it is important for their patients. Video: https://congressreport.eu/scientific-contents/standalonecontent:long-term-efficacy-and-safety-ixekizumab The full article: Long-term...

Professor Ulrich Laufs talk about a very challenging topic, secondary cardiovascular prevention. At the European Atherosclerosis Society annual meeting he had a lecture, the ESC/EAS joint session about the societies prevention guideline, focusing on secondary prevention. Video: https://congressreport.eu/scientific-contents/interview:esceas-joint-session-what-new-secondary-cv-prevention

Professor Ian Graham shared us the advances of the cardiovascular risk collaboration he spoke about of the ESC/EAS joint session at EAS 2022. Video: https://congressreport.eu/scientific-contents/interview:esceas-joint-session-advances-cv-risk-estimation-focus-dyslipidemia

Professor Margarida Gonçalo shared with us one of the session of the recent EADV Symposium took place in Ljubljana. The topic was chronic urticaria. Video: https://congressreport.eu/scientific-contents/interview:treatment-options-chronic-urticaria

Professor Federico Cappuzzo summarize the program of the Summit held in Rome. During the sessions was discussed various aspects in the field of lung cancer. Like new biomarkers for prevention and screening for patients with lung cancer, neoadjuvant therapies, treatment of metastatic disease, new immunotherapy options and targeted therapies. Video: https://congressreport.eu/scientific-contents/inte...

Professor Daniel Scherr co-chaired a very interesting symposium at the recent EHRA 2022 congress, how the can physicians better use the guidelines. We asked professor Scherr to summarize the most important take away messages from this symposium. Video: https://congressreport.eu/scientific-contents/interview:atrial-fibrillation-guidelines-clinical-practice

Professor Hung-Fat Tse is an expert on the field on pacing, and recently co-chaired a very interesting symposium at the EHRA 2022 about the recent developments of conduction system pacing. Video: https://congressreport.eu/scientific-contents/interview:recent-developments-conduction-system-pacing

Professor Michael Glikson co-chaired the European Society of Cardiology guidelines on cardiac pacing, and now he speaks for us about the part of this huge document that deals with conduction system pacing. What do the new guidelines tell us? Video: https://congressreport.eu/scientific-contents/interview:what-do-new-guidelines-tell-us-about-conduction-system-pacing

Professor Mauro Biffi speak us about the data that were presented at the recent European Heart Rhythm Association meeting. The session he talking about was about conduction system pacing, a novel modality of cardiac stimulation. Video: https://congressreport.eu/scientific-contents/interview:conduction-system-pacing-ready-prime-time

Professor Marc Bonaca co-moderated a session at the American College of Cardiology meeting that was focused on the care of patients with advanced vascular disease. Specifictly diseases in the lower extremities, the legs and the arms called peripheral arterial disease. Video: https://congressreport.eu/scientific-contents/interview:antithrombotic-approaches-reduce-risk-secondary-event-cad-and-pad